Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.). Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on Behalf of Icon Canada Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on Behalf of Icon Canada Inc.). Canadian Agency for Drugs and Technologies in Health, 2017.
